Controversial antidepressant FDA approved; New app for medical students; 75% of infants with COVID born to unvaxxed women - Morning Medical Update

Controversial antidepressant FDA approved

After two decades, the Food and Drug Administration has approved gepirone hydrochloride extended-release (ER; Exxua). Gepirone ER is the first approved antidepressant that specifically targets the serotonin 1A receptor. It’s expected to arrive at pharmacies in early 2024.

New app for medical students

Medical students have developed an app to teach fellow students how to talk to patients. Eddie Guo, a second-year student at the University of Calgary and resident Dr. Mehul Gupta, MD created the OSCE-GPT, where the computer is the patient. The app is available for free and over 500 people from across the world signed on in the first month.

75% of infants with COVID born to unvaxxed women

A new study shows that 75% of infants with COVID were born to unvaccinated women. Obstetrician-gynecologists were most likely to recommend the vaccine to pregnant mothers. Study authors say that recommendations from more primary care providers could help spread vaccine awareness. "Maternal vaccination coverage remains suboptimal," the authors said in a press release.